Pivotal Phase III study demonstrates substantial symptom relief in patients with systemic juvenile idiopathic arthritis treated with canakinumab

被引：0
|
作者：
不详
机构：
来源：
EXPERT REVIEW OF CLINICAL IMMUNOLOGY | 2011年 / 7卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：721 / 721
页数：1
相关论文
共 50 条
  • [41] Juvenile idiopathic arthritis with systemic onset with inflammatory bone lesions: two case reports of patients successfully treated with canakinumab and experience gained from literature
    Alexeeva, Ekaterina I.
    Dvoryakovskaya, Tatyana M.
    Tsulukiya, Irina T.
    Kondrateva, Natalia M.
    Solomatina, Natalia M.
    Kondratiev, Gleb V.
    Peshekhonova, Luliia V.
    Kostik, Mikhail M.
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [42] CHANGES IN HEALTH-RELATED QUALITY OF LIFE IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS PATIENTS AFTER SINGLE DOSE OF CANAKINUMAB
    Wulffraat, N.
    Kallinich, T.
    McCann, L.
    Brik, R.
    Rutkowska-Sak, L.
    Ferrandiz, M.
    Lheritier, K.
    Kim, D.
    Gnanasakthy, A.
    Ozdogan, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 266 - 267
  • [43] Canakinumab Treatment in Patients with Still's Disease: A Pooled Analysis of Systemic Juvenile Idiopathic Arthritis Data By Age Groups
    Feist, Eugen
    Quartier, Pierre
    Fautrel, Bruno
    Schneider, Rayfel
    Sfriso, Paolo
    Efthimiou, Petros
    Cantarini, Luca
    Lheritier, Karine
    Leon, Karolynn
    Speziale, Antonio
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [44] CANAKINUMAB IS A RESCUE TREATMENT FOR MACROPHAGE ACTIVATION SYNDROME IN PATIENTS WITH SYSTEMIC ONSET JUVENILE IDIOPATHIC ARTHRITIS: SINGLE CENTER EXPERIENCE
    Kostik, M.
    Isupova, E.
    Chikova, I.
    Likhacheva, T.
    Masalova, V.
    Snegireva, L.
    Dubko, M.
    Gaidar, E.
    Kaneva, M.
    Kornishina, T.
    Kalashnikova, O.
    Chasnyk, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 937 - 937
  • [45] Macrophage Activating Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Biological Drugs
    Sozeri, Betul
    Barut, Kenan
    Atalay, Erdal
    Kisaarslan, Aysenur Pac
    Ozdel, Semanur
    Altug, Ozge
    Demir, Ferhat
    Makay, Balahan
    Ayaz, Nuray Aktay
    Acar, Ersen
    Haslak, Fatih
    Sag, Erdal
    Yildiz, Mehmet
    Akca, Ummusen Kaya
    Adrovic, Amra
    Bilginer, Yelda
    Poyrazoglu, Hakan
    Unsal, Erbil
    Kasapcopur, Ozgur
    Ozen, Seza
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 499 - 500
  • [46] The Randomized Placebo Phase Study of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis
    Ilowite, Norman T.
    Prather, Kristi
    Lokhnygina, Yuliya
    Schanberg, Laura E.
    Elder, Melissa
    Milojevic, Diana
    Verbsky, James W.
    Spalding, Steven J.
    Kimura, Yukiko
    Imundo, Lisa F.
    Punaro, Marilynn G.
    Sherry, David D.
    Tarvin, Stacey E.
    Zemel, Lawrence S.
    Birmingham, James D.
    Gottlieb, Beth S.
    Miller, Michael L.
    O'Neil, Kathleen M.
    Ruth, Natasha M.
    Wallace, Carol A.
    Singer, Nora G.
    Sandborg, Christy I.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S757 - S758
  • [47] Reasons for Initiation of Canakinumab of Patients with Systemic Juvenile Idiopathic Arthritis: A Retrospective Medical Chart Review from the United States
    Hur, Peter
    Ionescu-Ittu, Raluca
    Manceur, Ameur M.
    Lomax, Kathleen G.
    Cammarota, Jordan
    Xie, Jipan
    Sanghera, Navneet
    Grom, Alexei A.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [48] A DESCRIPTIVE RETROSPECTIVE STUDY OF JUVENILE IDIOPATHIC ARTHRITIS PATIENTS WITH TREATED BIOLOGICAL
    Moruno-Cruz, H.
    Romero Bogado, M. L.
    Pretel Ruiz, P.
    Perez Gomez, A.
    Clemente Garulo, D.
    Turrion Nieves, A.
    Movasat, A.
    Bohorquez, C.
    Cuende, E.
    Albarran, F.
    Sanchez, A.
    Lopez Robledillo, J. C.
    Alvarez-Mon, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1199 - 1199
  • [49] Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis: Results from an Open-Label Long-Term Followup Study
    Brunner, Hermine L.
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin, Tamas
    Alexeeva, Ekaterina
    Schneider, Rayfel
    Kone-Paut, Isabelle
    Schikler, Kenneth
    Marzan, Katherine
    Wulffraat, Nico
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny L.
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Speziale, Antonio
    Lheritier, Karine
    Vritzali, Eleni
    Lovell, Daniel J.
    Martini, Alberto
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [50] Evaluation of clinical outcomes in systemic juvenile idiopathic arthritis patients treated with biological agents in Turkey: the TURSIS study
    Sozeri, B.
    Demir, F.
    Barut, K.
    Atalay, E.
    Kisaarslan, A. Pac
    Ozdel, S.
    Gucenmez, O. Altug
    Makay, B.
    Ayaz, N. Aktay
    Haslak, F.
    Sag, E.
    Yildiz, M.
    Akca, U. Kaya
    Adrovic, A.
    Bilginer, Y.
    Poyrazoglu, H.
    Unsal, E.
    Kasapcopur, O.
    Ozen, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (01) : 194 - 201
12345